An evaluation study fo efficacy and safety ob Robotic total hysterectomy with Da vinci Surgical System for uterine cancer

An evaluation study fo efficacy and safety ob Robotic total hysterectomy with Da vinci Surgical System for uterine cancer - An evaluation of uterine cancer total hysterectomy with Da vinci

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030406

Enrollment

Registered

2017-12-15

Start date

2013-11-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

uterine corpus cancer

Interventions

otal hysterectomy with Da Vinci Surgical System

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1) histrogically and radiologically judged uterine cancer 2) applicable to video-assisted total hysterectomy 3) age 20 to 80 years 4) ECOG-Performance status of 0 to 1 5) written informed consent

Exclusion criteria

Exclusion criteria: 1) severe cardiac or cerebral vascular disease 2) aspirin, warfarin or other medications induce bleeding tendency prohibited to discontinue 3) sever renal disfunction 4) severe hepatic disfunction 5) patients whose enrollement in this trial is judged to be inappropriate by the attending doctor.

Design outcomes

Primary

Measure	Time frame
Perioperative Morbidity and Mortality (Clavien-Dindo classification 2 or higher).	—

Secondary

Measure	Time frame
Surgical outcomes (operation time, volume of blood loss, and conversion rate to open surgery)	—

Countries

Japan

Contacts

Public ContactYasuyuki Hasuo

ational Hospital Organization Kyushu Medical Center Department of Gynecology

hasuo@kyumed.jp092-852-0700

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026